ALEXANDRA HARRIS: Open Payments
NPI 1154824803 · GREENVILLE, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$293 in 13 payments from 8 companies in 2025. Trend: 2023 $322 · 2024 $211 · 2025 $293
Food & beverage: $293
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $66 |
| SCPHARMACEUTICALS INC. | 1 | $47 |
| BridgeBio Pharma, Inc. | 2 | $40 |
| E.R. Squibb & Sons, L.L.C. | 2 | $38 |
| PFIZER INC. | 2 | $35 |
| Alnylam Pharmaceuticals Inc. | 1 | $28 |
| VivaQuant Inc, dba Rhythm Express | 1 | $25 |
| Merck Sharp & Dohme LLC | 1 | $14 |
Products named: Kerendia, FUROSCIX, Attruby, VYNDAQEL, AMVUTTRA, RHYTHM EXPRESS, ELIQUIS, CAMZYOS.
Industry payments across MS — which companies pay providers there.
